Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paroxetine for Cardiac Remodeling After Acute Myocardial Infarction
NCT03274752Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Oct 2017
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paroxetine in cardiac remodeling, sponsored by Insel Gruppe. Started Oct 2017; status: completed.
02
Drugs
paroxetine
03
Conditions
cardiac remodeling
Beyond the preview
Go deeper on NCT03274752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274752.